छोड़कर सामग्री पर जाएँ

Buy Piramal Pharma; target of Rs 180: ICICI Securities

ICICI Securities is bullish on Piramal Pharma recommended buy rating on the stock with a target price of Rs 180 in its research report dated February 01, 2024.

Read More

​ ICICI Securities is bullish on Piramal Pharma recommended buy rating on the stock with a target price of Rs 180 in its research report dated February 01, 2024. ICICI Securities is bullish on Piramal Pharma recommended buy rating on the stock with a target price of Rs 180 in its research report dated February 01, 2024.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी